- Tytuł:
- Comparison of thrombotic adverse events in patients treated with factor VIII products and emicizumab using the 2018-2022 US Food and Drug Administration Adverse Event Reporting System data
- Autorzy:
- Źródło:
- In Journal of Thrombosis and Haemostasis February 2024
Czasopismo naukowe